Indeed, the results of our meta-analysis show that salivary chemerin is significantly elevated in OC patients compared with healthy controls and participants with OPMD, suggesting that it may serve as a potential OC biomarker. Here, RARRES2 is linked to oculopharyngeal muscular dystrophy.